-
1
-
-
34250650032
-
Zero tolerance
-
Prowse C. Zero tolerance. Transfusion 2007 47 : 1106 9.
-
(2007)
Transfusion
, vol.47
, pp. 1106-1109
-
-
Prowse, C.1
-
2
-
-
36348962917
-
Pathogen inactivation: Making decisions about new technologies - Report of a consensus conference
-
DOI 10.1111/j.1537-2995.2007.01512.x
-
Klein HG, Anderson D, Bernardi MJ, Cable R, Hoch JS, Robitaille N, Sivilotti ML, Smaill F. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007 47 : 2338 47. (Pubitemid 350151213)
-
(2007)
Transfusion
, vol.47
, Issue.12
, pp. 2338-2347
-
-
Klein, H.G.1
Anderson, D.2
Bernardi, M.-J.3
Cable, R.4
Carey, W.5
Hoch, J.S.6
Robitaille, N.7
Sivilotti, M.L.A.8
Smaill, F.9
-
3
-
-
36649022874
-
Proceedings of a consensus conference: Pathogen inactivation - Making decisions about new technologies
-
Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA. Proceedings of a consensus conference: pathogen inactivation - making decisions about new technologies. Transfus Med Rev 2008 22 : 1 34.
-
(2008)
Transfus Med Rev
, vol.22
, pp. 1-34
-
-
Webert, K.E.1
Cserti, C.M.2
Hannon, J.3
Lin, Y.4
Pavenski, K.5
Pendergrast, J.M.6
Blajchman, M.A.7
-
4
-
-
0026669973
-
Manufacture and in vitro characterization of a solvent/detergent-treated human plasma
-
Hellstern P, Sachse H, Schwinn H, Oberfrank K. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma. Vox Sang 1992 63 : 178 85.
-
(1992)
Vox Sang
, vol.63
, pp. 178-185
-
-
Hellstern, P.1
Sachse, H.2
Schwinn, H.3
Oberfrank, K.4
-
5
-
-
0033485345
-
Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity
-
Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ. Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity. Blood 1999 94 : 3922 7.
-
(1999)
Blood
, vol.94
, pp. 3922-3927
-
-
Mast, A.E.1
Stadanlick, J.E.2
Lockett, J.M.3
Dietzen, D.J.4
-
6
-
-
0035120295
-
A potentially improved approach to methylene blue virus inactivation of plasma: The Maco Pharma Maco-Tronic system
-
Hornsey VS, Drummond O, Young D, Docherty A, Prowse CV. A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system. Transfus Med 2001 11 : 31 6.
-
(2001)
Transfus Med
, vol.11
, pp. 31-36
-
-
Hornsey, V.S.1
Drummond, O.2
Young, D.3
Docherty, A.4
Prowse, C.V.5
-
7
-
-
37549049779
-
Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: Methylene blue and amotosalen
-
Osselaer JC, Debry C, Goffaux M, Pineau J, Calomme G, Dubuc E, Chatelain B, Vandenidaele MC, Hsu J, Rheinschmidt M, Lin L. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 2008 48 : 108 17.
-
(2008)
Transfusion
, vol.48
, pp. 108-117
-
-
Osselaer, J.C.1
Debry, C.2
Goffaux, M.3
Pineau, J.4
Calomme, G.5
Dubuc, E.6
Chatelain, B.7
Vandenidaele, M.C.8
Hsu, J.9
Rheinschmidt, M.10
Lin, L.11
-
8
-
-
41149163375
-
Photochemical treatment of plasma with amotosalen and UVA light: Process validation in three European blood centers
-
Schlenke P, Hervig T, Isola H, Wiesel ML, Kientz D, Pinkoski L, Singh Y, Lin L, Corash L, Cazenave JP. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers. Transfusion 2008 48 : 697 705.
-
(2008)
Transfusion
, vol.48
, pp. 697-705
-
-
Schlenke, P.1
Hervig, T.2
Isola, H.3
Wiesel, M.L.4
Kientz, D.5
Pinkoski, L.6
Singh, Y.7
Lin, L.8
Corash, L.9
Cazenave, J.P.10
-
9
-
-
62349093765
-
Processing and components: Leucoreduction and pathogen reduction
-
In. Barbara, J.A. Regan, F.A. Contreras, M.C. editors. Cambridge. Cambridge University Press. p.
-
Cardigan R, Prowse C, Williamson LM. Processing and components: leucoreduction and pathogen reduction. In : Barbara JA, Regan FA, Contreras MC, editors. Transfusion microbiology. Cambridge : Cambridge University Press 2008. p. 239 58.
-
(2008)
Transfusion Microbiology
, pp. 239-258
-
-
Cardigan, R.1
Prowse, C.2
Williamson, L.M.3
-
10
-
-
33644893088
-
Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light
-
Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006 90 : 85 91.
-
(2006)
Vox Sang
, vol.90
, pp. 85-91
-
-
Cardo, L.J.1
Rentas, F.J.2
Ketchum, L.3
Salata, J.4
Harman, R.5
Melvin, W.6
Weina, P.J.7
Mendez, J.8
Reddy, H.9
Goodrich, R.10
-
11
-
-
33645289412
-
Functional inactivation of white blood cells by Mirasol treatment
-
Fast LD, DiLeone G, Li J, Goodrich R. Functional inactivation of white blood cells by Mirasol treatment. Transfusion 2006 46 : 642 8.
-
(2006)
Transfusion
, vol.46
, pp. 642-8
-
-
Fast, L.D.1
Dileone, G.2
Li, J.3
Goodrich, R.4
-
12
-
-
33846417644
-
Inactivation of Orientia tsutsugamushi in red blood cells, plasma and platelets with riboflavin and light, as demonstrated in an animal model
-
Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, Lippert L, Montgomery J, Richards A, Chan C, Jiang J, Reddy H, Li J, Goodrich R. Inactivation of Orientia tsutsugamushi in red blood cells, plasma and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion 2007 47 : 240 7.
-
(2007)
Transfusion
, vol.47
, pp. 240-7
-
-
Rentas, F.1
Harman, R.2
Gomez, C.3
Salata, J.4
Childs, J.5
Silva, T.6
Lippert, L.7
Montgomery, J.8
Richards, A.9
Chan, C.10
Jiang, J.11
Reddy, H.12
Li, J.13
Goodrich, R.14
-
13
-
-
2942558817
-
Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light
-
Ruane PH, Edrich R, Gampp D, Keil SD, Leonard L, Goodrich RP. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004 44 : 877 85.
-
(2004)
Transfusion
, vol.44
, pp. 877-85
-
-
Ruane, P.H.1
Edrich, R.2
Gampp, D.3
Keil, S.D.4
Leonard, L.5
Goodrich, R.P.6
-
14
-
-
33748445931
-
The Mirasol™ PRT system for pathogen reduction of platelets and plasma: An overview of current status and future trends
-
Goodrich RP, Edrich RA, Li J, Seghatchian J. The Mirasol™ PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006 35 : 5 17.
-
(2006)
Transfus Apher Sci
, vol.35
, pp. 5-17
-
-
Goodrich, R.P.1
Edrich, R.A.2
Li, J.3
Seghatchian, J.4
-
15
-
-
4644239596
-
Riboflavin and UV-light based pathogen reduction: Extent and consequence of DNA damage at the molecular level
-
Kumar V, Lockerbie O, Keil SD, Ruane PH, Platz MS, Martin CB, Ravanat JL, Cadet J, Goodrich RP. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 2004 80 : 15 21.
-
(2004)
Photochem Photobiol
, vol.80
, pp. 15-21
-
-
Kumar, V.1
Lockerbie, O.2
Keil, S.D.3
Ruane, P.H.4
Platz, M.S.5
Martin, C.B.6
Ravanat, J.L.7
Cadet, J.8
Goodrich, R.P.9
-
16
-
-
40749148572
-
Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation
-
Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 2008 22 : 133 53.
-
(2008)
Transfus Med Rev
, vol.22
, pp. 133-53
-
-
Reddy, H.L.1
Dayan, A.D.2
Cavagnaro, J.3
Gad, S.4
Li, J.5
Goodrich, R.P.6
-
17
-
-
0016865340
-
A method for assaying von Willebrand factor (ristocetin cofactor)
-
Macfarlane DE, Stibbe J, Kirby EP, Zucher MB, Gant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975 34 : 306 8.
-
(1975)
Thromb Diath Haemorrh
, vol.34
, pp. 306-8
-
-
MacFarlane, D.E.1
Stibbe, J.2
Kirby, E.P.3
Zucher, M.B.4
Gant, R.A.5
McPherson, J.6
-
18
-
-
0032569840
-
Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
-
Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998 339 : 1585 94.
-
(1998)
N Engl J Med
, vol.339
, pp. 1585-94
-
-
Tsai, H.M.1
Lian, E.C.2
-
19
-
-
0019442145
-
The complex multimeric structure composition of factor VIII/von Willebrand factor
-
Ruggeri ZM, Zimmerman TS. The complex multimeric structure composition of factor VIII/von Willebrand factor. Blood 1981 57 : 1140 3.
-
(1981)
Blood
, vol.57
, pp. 1140-3
-
-
Ruggeri, Z.M.1
Zimmerman, T.S.2
-
20
-
-
9644266966
-
Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura
-
Snider CE, Moore JC, Warkentin TE, Finch CN, Hayward CP, Kelton JG. Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura. Am J Hematol 2004 77 : 387 90.
-
(2004)
Am J Hematol
, vol.77
, pp. 387-90
-
-
Snider, C.E.1
Moore, J.C.2
Warkentin, T.E.3
Finch, C.N.4
Hayward, C.P.5
Kelton, J.G.6
-
23
-
-
0034490673
-
The effect of virus inactivation on coagulation factors in therapeutic plasma
-
Zeiler T, Wittmann G, Zimmermann R, Hintz G, Huhn D, Reiss H. The effect of virus inactivation on coagulation factors in therapeutic plasma. Br J Haematol 2000 111 : 986 7.
-
(2000)
Br J Haematol
, vol.111
, pp. 986-7
-
-
Zeiler, T.1
Wittmann, G.2
Zimmermann, R.3
Hintz, G.4
Huhn, D.5
Reiss, H.6
-
24
-
-
0038057391
-
Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma
-
Doyle S, O'Brien P, Murphy K, Fleming C, O'Donnell J. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 2003 14 : 283 7.
-
(2003)
Blood Coagul Fibrinolysis
, vol.14
, pp. 283-7
-
-
Doyle, S.1
O'Brien, P.2
Murphy, K.3
Fleming, C.4
O'Donnell, J.5
-
25
-
-
1842715059
-
Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura
-
Yarranton H, Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfus Med 2004 14 : 39 44.
-
(2004)
Transfus Med
, vol.14
, pp. 39-44
-
-
Yarranton, H.1
Lawrie, A.S.2
Purdy, G.3
MacKie, I.J.4
MacHin, S.J.5
-
26
-
-
35248876717
-
Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma
-
Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma. Biologicals 2007 35 : 349 53.
-
(2007)
Biologicals
, vol.35
, pp. 349-53
-
-
Burnouf, T.1
Goubran, H.A.2
Radosevich, M.3
Sayed, M.A.4
Gorgy, G.5
El-Ekiaby, M.6
-
28
-
-
47249144803
-
Von Willebrand factor, ADAMTS13 and thrombotic thrombocytopenic purpura
-
Sadler JE. Von Willebrand factor, ADAMTS13 and thrombotic thrombocytopenic purpura. Blood 2008 112 : 11 8.
-
(2008)
Blood
, vol.112
, pp. 11-8
-
-
Sadler, J.E.1
-
29
-
-
8144222749
-
Cryoprecipitate prepared from plasma treated with methylene blue plus light: Increasing the fibrinogen concentration
-
Hornsey VS, Young DA, Docherty A, Hughes W, Prowse CV. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration. Transfus Med 2004 14 : 369 74.
-
(2004)
Transfus Med
, vol.14
, pp. 369-74
-
-
Hornsey, V.S.1
Young, D.A.2
Docherty, A.3
Hughes, W.4
Prowse, C.V.5
-
30
-
-
4243405717
-
Preparation of cryoprecipitate from photochemically treated fresh frozen plasma
-
Suppl
-
Mintz PD, Avery NL, Moulaison SL, Flanagan HL, Boyd JC, Eden P, Johnson S, Smyers J, Wages D. Preparation of cryoprecipitate from photochemically treated fresh frozen plasma. Transfusion 2000 40 Suppl : SP71.
-
(2000)
Transfusion
, vol.40
, pp. 71
-
-
Mintz, P.D.1
Avery, N.L.2
Moulaison, S.L.3
Flanagan, H.L.4
Boyd, J.C.5
Eden, P.6
Johnson, S.7
Smyers, J.8
Wages, D.9
-
31
-
-
0031014520
-
Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method
-
Keeling DM, Luddington R, Allain JP, Lawrie AS, Williamson LM. Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method. Br J Haematol 1997 96 : 194 7.
-
(1997)
Br J Haematol
, vol.96
, pp. 194-7
-
-
Keeling, D.M.1
Luddington, R.2
Allain, J.P.3
Lawrie, A.S.4
Williamson, L.M.5
-
32
-
-
23844532601
-
Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction
-
AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005 45 : 1335 41.
-
(2005)
Transfusion
, vol.45
, pp. 1335-41
-
-
Aubuchon, J.P.1
Herschel, L.2
Roger, J.3
Taylor, H.4
Whitley, P.5
Li, J.6
Edrich, R.7
Goodrich, R.P.8
-
33
-
-
70350454807
-
-
System (prt) Technology Reduction Pathogen Mirasol® G. P R. Summary Of Results From The Miracle trial [cited 2009 Jun 1]. Available from URL
-
Goodrich RP. Mirasol® pathogen reduction technology (PRT) system: summary of results from the MIRACLE trial. CaridianBCT Biotechnologies. 2009. [cited 2009 Jun 1]. Available from URL: http://www.caridianbct.com/cps/rde/xbcr/ SID-3916ADC2-1C0EF723/caridianbct/306690173-web.pdf
-
(2009)
CaridianBCT Biotechnologies
-
-
-
34
-
-
0242677709
-
Universal fresh frozen plasma (Uniplas): A safe product in open-heart surgery
-
Tollofsrud S, Noddeland H, Svennevig JL, Bentsen G, Mollnes TE, Solheim BG. Universal fresh frozen plasma (Uniplas): a safe product in open-heart surgery. Intensive Care Med 2003 29 : 1736 43.
-
(2003)
Intensive Care Med
, vol.29
, pp. 1736-43
-
-
Tollofsrud, S.1
Noddeland, H.2
Svennevig, J.L.3
Bentsen, G.4
Mollnes, T.E.5
Solheim, B.G.6
-
35
-
-
13544277096
-
Solvent/detergent-treated plasma: Composition, efficacy and safety
-
Hellstern P. Solvent/detergent-treated plasma: composition, efficacy and safety. Curr Opin Hematol 2004 1 : 346 50.
-
(2004)
Curr Opin Hematol
, vol.1
, pp. 346-50
-
-
Hellstern, P.1
-
36
-
-
0038692734
-
Methylene blue-treated fresh-frozen plasma: What is its contribution to blood safety?
-
Williamson LM, Cardigan R, Prowse CV. Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion 2003 43 : 1322 9.
-
(2003)
Transfusion
, vol.43
, pp. 1322-9
-
-
Williamson, L.M.1
Cardigan, R.2
Prowse, C.V.3
-
37
-
-
34247331490
-
Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience
-
Politis C, Kavallierou L, Hantziara S, Katsea P, Triantaphylou V, Richardson C, Tsoutsos D, Anagnostopoulos N, Gorgolidis G, Ziroyannis P. Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience. Vox Sang 2007 92 : 319 26.
-
(2007)
Vox Sang
, vol.92
, pp. 319-26
-
-
Politis, C.1
Kavallierou, L.2
Hantziara, S.3
Katsea, P.4
Triantaphylou, V.5
Richardson, C.6
Tsoutsos, D.7
Anagnostopoulos, N.8
Gorgolidis, G.9
Ziroyannis, P.10
-
38
-
-
23844453081
-
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: Transfusion of patients with congenital coagulation factor deficiencies
-
de Alarcon P, Benjamin R, Dugdale M, Kessler C, Shopnick R, Smith P, Abshire T, Hambleton J, Matthew P, Ortiz I, Cohen A, Konkle BA, Streiff M, Lee M, Wages D, Corash L. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion 2005 45 : 1362 72.
-
(2005)
Transfusion
, vol.45
, pp. 1362-72
-
-
De Alarcon, P.1
Benjamin, R.2
Dugdale, M.3
Kessler, C.4
Shopnick, R.5
Smith, P.6
Abshire, T.7
Hambleton, J.8
Matthew, P.9
Ortiz, I.10
Cohen, A.11
Konkle, B.A.12
Streiff, M.13
Lee, M.14
Wages, D.15
Corash, L.16
-
39
-
-
33748950122
-
A randomised, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura
-
Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG. A randomised, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Transfusion 2006 46 : 1693 704.
-
(2006)
Transfusion
, vol.46
, pp. 1693-704
-
-
Mintz, P.D.1
Neff, A.2
MacKenzie, M.3
Goodnough, L.T.4
Hillyer, C.5
Kessler, C.6
McCrae, K.7
Menitove, J.E.8
Skikne, B.S.9
Damon, L.10
Lopez-Plaza, I.11
Rouault, C.12
Crookston, K.P.13
Benjamin, R.J.14
George, J.15
Lin, J.S.16
Corash, L.17
Conlan, M.G.18
-
40
-
-
51249088766
-
Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: A multicentric, prospective cohort study
-
del Rio-Garma J, Alvarez-Larran A, Martinez C, Muncunill J, Castella D, de la Rubia J, Zamora C, Corral M, Viejo A, Pena F, Rodriguez-Vicente P, Contreras E, Arbona C, Ramirez C, Garcia-Erce JA, Alegre A, Mateo J, Pereira A. Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study. Br J Haematol 2008 143 : 39 45.
-
(2008)
Br J Haematol
, vol.143
, pp. 39-45
-
-
Del Rio-Garma, J.1
Alvarez-Larran, A.2
Martinez, C.3
Muncunill, J.4
Castella, D.5
De La Rubia, J.6
Zamora, C.7
Corral, M.8
Viejo, A.9
Pena, F.10
Rodriguez-Vicente, P.11
Contreras, E.12
Arbona, C.13
Ramirez, C.14
Garcia-Erce, J.A.15
Alegre, A.16
Mateo, J.17
Pereira, A.18
-
41
-
-
0030012014
-
Plasma ascorbate protects coagulation factors against photooxidation
-
Parkkinen J, Vaaranen O, Vahtera E. Plasma ascorbate protects coagulation factors against photooxidation. Thromb Haemost 1996 75 : 292 7.
-
(1996)
Thromb Haemost
, vol.75
, pp. 292-7
-
-
Parkkinen, J.1
Vaaranen, O.2
Vahtera, E.3
|